HIP: Transcultural and Psychometric Validation of SUSHI and HOOS-12 Scores in Patients With Coxofemoral Pathologies

Sponsor
University Hospital Center of Martinique (Other)
Overall Status
Recruiting
CT.gov ID
NCT04470232
Collaborator
Lariboisière Hospital (Other), Saint-Gregoire Private Hospital Center (Other)
120
3
29.6
40
1.4

Study Details

Study Description

Brief Summary

The management of coxofemoral pathologies is constantly increasing.

In addition to degenerative hip pathology, the orthopedic surgeon is now confronted with pathologies such as femoro-acetabular conflict, pathologies of the gluteus medius and pathologies of the labrum whose early management limits arthritis degeneration. These pathologies are mainly encountered in young subjects (<60 years).

Self-questionnaires play an important role in understanding patients' point of view on the impact of their coxofemoral pathologies and also allow an assessment of their condition after treatment.

For the evaluation of coxofemoral pathologies in the young subject (<60 years) the Super Simple Hip score (SUSHI-score) was developed and validated.

In the elderly subject with hip osteoarthritis, the HOOS score has the advantage of specifically measuring pain, symptoms, function and quality of life, but is made up of 40 items and is often considered rather heavy to submit. However, it has recently been simplified and the HOOS-12 (HOOS score with 12 items) has been developed and validated.

These two scores are useful in current clinical practice but they are only validated in English.

Condition or Disease Intervention/Treatment Phase
  • Other: Self-assessment questionnaires

Study Design

Study Type:
Observational
Anticipated Enrollment :
120 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Transcultural and Psychometric Validation of SUSHI and HOOS-12 Scores in Patients With Coxofemoral Pathologies
Actual Study Start Date :
Sep 11, 2020
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Mar 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Patients with coxofemoral pathologies

For the transcultural validation, a french version of the 2 self-assessment questionnaires, SUSHI-score and the HOOs-12 score will be produced. For the psychometric validation, 120 patients with coxofemoral pathologies will pass the two questionnaires. The HAGOS (Hip and Groin Score) questionnaire will be also passed by the subject, for the convergent validity.

Other: Self-assessment questionnaires
120 patients with coxofemoral pathologies will pass the SUSHI-score and the HOOS-12 score questionnaires. The HAGOS (Hip and Groin Score) questionnaire will be also passed by the subject, for the convergent validity.

Outcome Measures

Primary Outcome Measures

  1. Transcultural validation of the SUSHI-score and HOOS-12 score questionnaire [1 month]

    It will be a question of obtaining a version translated into French. The translated version tested on a small group of patients (15) will be submitted to the author of the original version of the tool, along with a report highlighting and explaining all the modifications and difficulties noted by a group of experts.

  2. Psychometric validation of the SUSHI-score and HOOS-12 score questionnaire [12 months]

    Questionnaires will be passed by 120 subjects. Following parameters will be measured: feasibility and acceptability, validity, reliability, and sensitivity to change.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patient (age greater than or equal to 18 years old),

  • Patient with coxofemoral pathology,

  • Patient having been informed of the research,

  • Patient agreeing to participate in the study.

Exclusion Criteria:
  • Minor patient,

  • Pregnant woman,

  • Patient out of state to agree to participate in the study,

  • Patient unable to answer a self-assessment questionnaire,

  • Patient under justice, guardianship or curatorship,

  • Patient who refused to participate in the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Lariboisière - AP-HP Paris France 75010
2 Centre Hospitalier Privé Saint-Grégoire Saint-Grégoire France 35760
3 CHU of Martinique Fort-de-France Martinique 97261

Sponsors and Collaborators

  • University Hospital Center of Martinique
  • Lariboisière Hospital
  • Saint-Gregoire Private Hospital Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital Center of Martinique
ClinicalTrials.gov Identifier:
NCT04470232
Other Study ID Numbers:
  • 20_RIPH3-03
First Posted:
Jul 14, 2020
Last Update Posted:
Jun 13, 2022
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital Center of Martinique

Study Results

No Results Posted as of Jun 13, 2022